StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Number of Animals Used in Preclinical Research at by Year

Number of Animals Used in Preclinical Research at Company Facilities

Novartis Number of Animals Used in Preclinical Research at: 241,420 in FY2025, up 4.5% from a year earlier.

Latest, FY2025
241,420
Period ended Dec 31, 2025
Change on a year earlier
+4.5%
230,924 in FY2024
History
2 years
Since FY2024
Sources
1
Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf

Where the FY2025 figure comes from

“| Animals needed to support research at own sites | 241 420 | 230 924 | 37”

Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Reported in ESG Data Summary 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNumber of Animals Used in Preclinical Research at Company FacilitiesYear on yearSource
FY2025Dec 31, 2025241,420+4.5%Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
FY2024Dec 31, 2024230,924–Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Cite this data

StockData. (2026). Novartis Number of Animals Used in Preclinical Research at, annual FY2024–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/rd-research-animals

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.